Overview


According to FutureWise analysis the market for balanced salt solutions is expected to reach US$ 3.25 billion by 2031 at a CAGR of 4.42%.

A combination of inorganic and organic salts, balanced salts often contain a carbohydrate to provide energy. Balanced Salt Solutions can be used to rinse cells and provide short-term maintenance for mammalian cells when they are not in their normal growth environment. These solutions maintain the correct osmotic pressure in cells and protect them against sharp pH fluctuations that can occur during laboratory manipulations. Balanced salt solutions containing calcium and magnesium salts can be used to wash and suspend cells during dissociation. Cell biology and cell culture are essential tools in molecular and cellular biology. They can be used to study cell function and its composition, and to also determine cell biology characteristics such as biochemistry and mutations, carcinogenic, and the effects of drug toxicity. The balance salt solution for cell culture is used to produce large quantities of Therapeutic proteins, vaccines, and screening and development of therapeutic drugs. Both its specificity, and exact composition are key factors in boosting the growth of the balanced salt solution market for cell culture.

In vitro cells are maintained their structural and physiological integrity by using balanced salt solutions. Gibco Balanced Salt Solutions, which are isotonic buffers systems, help maintain mammalian cells at a physiological pH range and high viability during short-term incubations.
The essential function of a balanced salt solution is to maintain pH and osmotic equilibrium, as well as supply water and essential inorganic elements to your cells. Gibco Balanced Salt Solutions come in many forms and formulations.

A balanced salt solution (BSS), is a solution that is made according to the physiological pH and isotonic sodium concentration. Most commonly, solutions include sodium, potassium, and calcium as well as magnesium and chloride. Balancing salt solutions can be used to wash cells and tissues. They are often combined with other agents to treat tissues and cells. They maintain a pH of 7.0 and an osmotic pressure of 8.0 in the cells. glucose can be added to energy sources, and phenol red is used as an indicator. Balanced salt solutions are used in medicine to provide irrigation, such as for intraocular operation or to replace intraocular fluids. The electrolyte composition in balanced salt solutions is very similar to that of extracellular fluid. There is lactated Ringer solution (similar in nature to Hartmann solution), Plasmalyte, and Normosol. These solutions are hypotonic in relation to sodium. To generate bicarbonate, the buffer added (e.g. lactate) is metabolized live.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Balanced Salt Solutions Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Balanced Salt Solutions Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific Inc
  • Lonza Group
  • Becton, Dickinson and Co
  • EMD Millipore
  • Coring Life Sciences B.V.
  • Wheaton Industries Inc
  • Promocell GmbH
  • Sigma-Aldrich
  • Bological Industry

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Hank's Balanced Salt Solution
  • Gey's Balanced Salt Solution
  • Earle's Balanced Salt Solutions
  • Dulbecco's Phosphate Buffered Saline
  • Others

By Application

  • Biopharmaceuticals Therapeutics
  • Stem Cell technology
  • Drug Screening and Development
  • Genetic Engineering
  • Cancer Research
  • Others

By End-User

  • Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Balanced Salt Solutions Market By Product Type, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Balanced Salt Solutions Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Balanced Salt Solutions Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Balanced Salt Solutions Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Balanced Salt Solutions Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hank's Balanced Salt Solution
        2. Gey's Balanced Salt Solution
        3. Earle's Balanced Salt Solutions
        4. Dulbecco's Phosphate Buffered Saline
        5. Others

  • 8.   Balanced Salt Solutions Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Biopharmaceuticals Therapeutics
        2. Stem Cell technology
        3. Drug Screening and Development
        4. Genetic Engineering
        5. Cancer Research
        6. Others

  • 9.   Balanced Salt Solutions Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research Institutes
        2. Pharmaceutical and Biotechnology Companies

  • 10.   North America Balanced Salt Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Balanced Salt Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Balanced Salt Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Balanced Salt Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Lonza Group
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. EMD Millipore
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Becton Dickinson and Co
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Coring Life Sciences B.V.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Wheaton Industries Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Promocell GmbH
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Sigma-Aldrich
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Bological Industry
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients